LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Universidad de Mondragón/Mondragon Unibertsitatea
Mondragón, EspañaPublicacións en colaboración con investigadores/as de Universidad de Mondragón/Mondragon Unibertsitatea (10)
2024
-
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
npj Parkinson's Disease, Vol. 10, Núm. 1
2023
-
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829
2022
-
Amygdala-hippocampus damage critically contributes to visual dysfunction in Parkinson disease
2022 International Congress on Movement Disorders
-
Deep learning applied to retinal OCT images to differentiate Parkinson’s disease patients from healthy controls
2022 International Congress on Movement Disorders
-
Heart-brain synchronization breakdown in Parkinson’s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Spatial characterization of the effect of age and sex on macular layer thicknesses and foveal pit morphology
PLoS ONE, Vol. 17, Núm. 12 December
2021
-
Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease
PLoS ONE, Vol. 16, Núm. 12 December
-
Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
Frontiers in Neuroscience, Vol. 15
-
Foveal pit morphology characterization: A quantitative analysis of the key methodological steps
Entropy, Vol. 23, Núm. 6
-
Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease
Annals of Neurology, Vol. 89, Núm. 1, pp. 165-176